Advances in brain barriers and brain fluid research and news from
                   by unknown
Drewes et al. Fluids Barriers CNS  (2016) 13:1 
DOI 10.1186/s12987-016-0026-1
EDITORIAL
Advances in brain barriers and brain 
fluid research and news from Fluids and Barriers 
of the CNS
Lester R. Drewes1, Hazel C. Jones2* and Richard F. Keep3
Abstract 
Research into brain barriers and brain fluids has been advancing rapidly in recent years. This editorial aims to high-
light some of the advances that have improved our understanding of this complex subject. It also brings you news of 
developments for Fluids and Barriers of the CNS including a new affiliation between the journal and the International 
Society for Hydrocephalus and CSF disorders.
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provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
The field of brain fluids and brain barriers
During the past 24  months there has continued to be 
an up-swell in interest in neurovascular unit (NVU)/
blood–brain barrier (BBB) and cerebrospinal fluid (CSF) 
research. That interest has led to many new and impor-
tant findings. For example, there continues to be an 
increasing interest in pericytes at the NVU. New experi-
ments [1] support initial findings [2, 3] on the importance 
of pericytes in BBB development, including regulation of 
endothelial transcytosis. There is also evidence that per-
icytes may have a role in control of cerebral blood flow 
[4] and are a target in ischemic stroke [4, 5]. Pericytes are 
now also being integrated into in vitro BBB models with 
some co-cultures showing permeabilities close to those 
in  vivo [6]. The use of human-derived pluripotent stem 
cells to produce endothelial cells, astrocytes and peri-
cytes to develop in  vitro NVU/BBB models holds great 
promise for the future [6, 7].
Fluid flow within the brain parenchyma continues to be 
an area of intense research. The glymphatic hypothesis, 
with perivascular flow into and out of the brain and astro-
cytic aquaporin-4 linked flow within the brain [8–11], 
continues to generate important data on the clearance 
of compounds from the brain in disease (e.g. [12, 13]) as 
well as the effects of parameters such as sleep and pos-
ture on such flow [14, 15]. There is also growing evidence 
that the brain has lymphatic vessels within the dura mater 
and these may be important in brain fluid drainage [16]. 
It should be noted, however, that there continues to be 
data showing that, in some regions, brain interstitial fluid 
flows to the cerebral ventricles and that (in rodents) a 
major outflow of CSF is via the subarachnoid space and 
across the cribriform plate [17]. In addition, while inter-
stitial fluid flow may be important in clearing compounds 
such as amyloid from the brain, the importance of clear-
ance at the NVU/BBB should not be overlooked and may 
be more important [18]. Advances in imaging techniques 
have contributed greatly to our understanding of the 
brain barriers and interstitial and CSF flow. Two-photon 
imaging has contributed greatly to animal studies (e.g. 
[9, 19] and novel magnetic resonance imaging (MRI) has 
led to evidence that inspiration has a greater effect on 
CSF flow than arterial pulsation [20]. This research is of 
great importance for hydrocephalus and other CSF dis-
orders. Hydrocephalus in various forms can arise at dif-
ferent stages of life (perinatal, mid-life and in the elderly), 
all with different and complex pathologies, none of which 
are fully understood. Surgical treatment for hydrocepha-
lus has been practiced, with many variations, for about 
50  years and has been beset with complications. Basic 
research on fluid flow into, within and out of the brain 
and on the removal of waste products is extremely impor-
tant for improving treatment for patients.
The field of drug delivery across the BBB and blood–
CSF barrier continues to present major challenges. There 
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is growing interest in using focused ultrasound to tran-
siently disrupt the NVU/BBB for drug delivery [21] and 
there is increasing evidence for the use intranasal delivery 
to circumvent the NVU/BBB [22]. As in any field, there 
are areas of controversy. For example, these include the 
relative role of the choroid plexus in brain fluid produc-
tion and the reader is referred to a number of reviews in 
this and other journals [10, 11, 23]. There is also renewed 
debate about the relative roles of different pathways in 
NVU/BBB disruption in disease. For example, in stroke, 
there is discussion about the relative role of tight junction 
disruption, transcytosis and endothelial cell death in the 
increased barrier permeability that occurs after cerebral 
ischemia [19, 24, 25]. Such debates are important in any 
field and are a spur for the development of new experimen-
tal approaches and technologies. There are also findings 
that cause marked surprise and promote new avenues for 
research. Thus, Braniste et al. found that germ-free mice, 
beginning in utero, have increased barrier permeability 
compared to pathogen-free mice with a normal gut micro-
biome [26]. These results suggest novel links between the 
gut microbiome and brain, a growing field of research.
One ultimate goal of biomedical research is the devel-
opment of new therapies. An area where new treatments 
are desperately needed is malignant cerebral edema, 
which is often associated with NVU/BBB disruption. It 
is, therefore, important to note that glyburide (gliben-
clamide) is now in phase II clinical trial for such edema 
in stroke (NCT01794182). Glyburide targets the sul-
fonylurea-1-transient receptor potential melastatin-4 
(Sur1-Trpm4) channel that is upregulated after stroke, 
including in cerebral endothelial cells [27, 28].
Journal metrics
All of these exciting areas of research are within the 
scope of Fluids and Barriers of the CNS (FBCNS). Dur-
ing 2015, FBCNS published on a wide range of topics 
covering different aspects of function and pathology of 
the NVU, the CSF response to pathogens, cancer metas-
tasis in the brain, MRI imaging in hydrocephalus, and 
brain interstitial fluid flow. The average number of jour-
nal accesses per month in 2015 taken from the BioMed 
Central website was 43,132. The most highly accessed 
papers in 2015 were: 12:3: The effects of Beta-Endorphin: 
state change modification [29]; 12:16: A new glaucoma 
hypothesis: a role of glymphatic system dysfunction [30]; 
12:4: Differential cytokine expression by brain microglia/
macrophages in primary culture after oxygen glucose dep-
rivation and their protective effects on astrocytes during 
anoxia [31]; and 12:5: Vascular endothelial growth factor 
blockade alters magnetic resonance imaging biomarkers 
of vascular function and decreases barrier permeability in 
a rat model of lung cancer brain metastasis [32].
In the past 3 years the number of citations for articles 
in FBCNS has risen steadily, as has the SCImago journal 
rank. The most highly cited article is Johanson et al: Mul-
tiplicity of cerebrospinal fluid functions: New challenges in 
health and disease [33].
Journal affiliations
The Editors of Fluids and Barriers of the CNS are very 
pleased to announce that FBCNS is now affiliated to the 
International Society for Hydrocephalus and CSF Dis-
orders (ISHCSF). This is in addition to affiliation to the 
International Brain Barriers Society (IBBS) set up in 2014. 
Thus Fluids and Barriers of the CNS is an official journal 
for both societies, this being a reflection of the full scope 
of the journal content. Society members enjoy a substan-
tial discount on the article submission fee needed to cover 
open access publishing costs. The ISHCSF was inaugu-
rated in September 2008 and is registered as a non-profit 
organization http://ishcsf.com. From the beginning, its 
mission has been to advance the art and science of the 
field of clinical care and research into hydrocephalus and 
CSF disorders, and thereby promote the best possible care 
for patients. It holds annual meetings and its aims are to 
promote international exchange, encourage worldwide 
representation and to stimulate research and debate. The 
Society supports standardized methods and ethically-
conducted clinical research and basic research in hydro-
cephalus, CSF disorders and related fields. In previous 
years, FBCNS has been interacting with ISHCSF through 
publication of a collection of members’ papers: thematic 
series Hydrocephalus: Promoting Research for Improved 
Outcomes (http://www.biomedcentral.com/collections/
hydrocephalus). In 2015 FBCNS published the abstracts 
from ISHCSF annual meeting in Banff, Canada (http://
www.fluidsbarrierscns.com/supplements/12/S1). We 
anticipate this new affiliation will lead to an increase in 
journal content in basic research into hydrocephalus and 
other CSF disorders and will stimulate further research 
leading to new ideas and treatment options for devastat-
ing neurological disorders. Our international editorial 
board has been expanded to reflect the affiliation with 
ISHCSF by strengthening the membership with expertise 
in neurosurgery, neuro- imaging and neurological disor-
ders, including hydrocephalus.
The future
There have been many recent advances in research on 
the brain barriers and fluids of the brain. Development of 
novel techniques, such as in imaging and better in vitro 
models should help in those advances. There is also a 
greater understanding of the importance of such research 
in disease states and treatments. FBCNS, with its focus 
on basic research into barriers, brain fluid dynamics and 
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associated diseases, aims to foster such advances. The 
affiliations with IBBS and ISHCSF will help in achieving 
that aim.
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